Spruce Biosciences Statistics
Total Valuation
SPRB has a market cap or net worth of $21.61 million. The enterprise value is -$55.65 million.
| Market Cap | 21.61M |
| Enterprise Value | -55.65M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SPRB has 41.15 million shares outstanding. The number of shares has increased by 28.83% in one year.
| Shares Outstanding | 41.15M |
| Shares Change (YoY) | +28.83% |
| Shares Change (QoQ) | +0.76% |
| Owned by Insiders (%) | 7.75% |
| Owned by Institutions (%) | 50.92% |
| Float | 24.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.13 |
| Forward PS | 4.38 |
| PB Ratio | 0.32 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.67, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.67 |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 72.27 |
Financial Efficiency
Return on equity (ROE) is -57.50% and return on invested capital (ROIC) is -72.93%.
| Return on Equity (ROE) | -57.50% |
| Return on Assets (ROA) | -43.40% |
| Return on Capital (ROIC) | -72.93% |
| Revenue Per Employee | $349,207 |
| Profits Per Employee | -$1.61M |
| Employee Count | 29 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.58% in the last 52 weeks. The beta is 2.42, so SPRB's price volatility has been higher than the market average.
| Beta (5Y) | 2.42 |
| 52-Week Price Change | -75.58% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 1.77 |
| Relative Strength Index (RSI) | 35.50 |
| Average Volume (20 Days) | 493,376 |
Short Selling Information
The latest short interest is 248,129, so 0.60% of the outstanding shares have been sold short.
| Short Interest | 248,129 |
| Short Previous Month | 121,674 |
| Short % of Shares Out | 0.60% |
| Short % of Float | 1.00% |
| Short Ratio (days to cover) | 0.43 |
Income Statement
In the last 12 months, SPRB had revenue of $10.13 million and -$46.75 million in losses. Loss per share was -$1.13.
| Revenue | 10.13M |
| Gross Profit | 10.13M |
| Operating Income | -51.43M |
| Pretax Income | -46.75M |
| Net Income | -46.75M |
| EBITDA | -47.11M |
| EBIT | -47.41M |
| Loss Per Share | -$1.13 |
Balance Sheet
The company has $81.15 million in cash and $3.89 million in debt, giving a net cash position of $77.26 million or $1.88 per share.
| Cash & Cash Equivalents | 81.15M |
| Total Debt | 3.89M |
| Net Cash | 77.26M |
| Net Cash Per Share | $1.88 |
| Equity (Book Value) | 66.62M |
| Book Value Per Share | 1.62 |
| Working Capital | 67.47M |
Cash Flow
In the last 12 months, operating cash flow was -$36.44 million and capital expenditures -$7,000, giving a free cash flow of -$36.45 million.
| Operating Cash Flow | -36.44M |
| Capital Expenditures | -7,000 |
| Free Cash Flow | -36.45M |
| FCF Per Share | -$0.89 |
Margins
Gross margin is 100.00%, with operating and profit margins of -507.82% and -461.67%.
| Gross Margin | 100.00% |
| Operating Margin | -507.82% |
| Pretax Margin | -461.67% |
| Profit Margin | -461.67% |
| EBITDA Margin | -465.20% |
| EBIT Margin | -468.14% |
| FCF Margin | -359.93% |
Dividends & Yields
SPRB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.83% |
| Shareholder Yield | -28.83% |
| Earnings Yield | -216.35% |
| FCF Yield | -168.67% |
Analyst Forecast
The average price target for SPRB is $2.50, which is 376.10% higher than the current price. The consensus rating is "Hold".
| Price Target | $2.50 |
| Price Target Difference | 376.10% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 28.94% |
| EPS Growth Forecast (5Y) | -12.51% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SPRB has an Altman Z-Score of -3.47 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.47 |
| Piotroski F-Score | 3 |